According to Dr. Reddy's's latest financial reports the company has a price-to-book ratio of 3.67.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.63 | 12.3% |
2022-12-31 | 3.23 | -24.69% |
2021-12-31 | 4.29 | -15.54% |
2020-12-31 | 5.08 | 58.75% |
2019-12-31 | 3.20 | -0.02% |
2018-12-31 | 3.20 | -0.91% |
2017-12-31 | 3.23 | -22.95% |
2016-12-31 | 4.19 | 1.84% |
2015-12-31 | 4.11 | -21.78% |
2014-12-31 | 5.26 | 3.95% |
2013-12-31 | 5.06 | 8.79% |
2012-12-31 | 4.65 | -9.69% |
2011-12-31 | 5.15 | -11.84% |
2010-12-31 | 5.84 | 22.8% |
2009-12-31 | 4.75 | 215.25% |
2008-12-31 | 1.51 | -43.4% |
2007-12-31 | 2.66 | -23.93% |
2006-12-31 | 3.50 | 5.9% |
2005-12-31 | 3.31 | -0.41% |
2004-12-31 | 3.32 | -37.28% |
2003-12-31 | 5.30 | -21.75% |
2002-12-31 | 6.77 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Novartis NVS | 4.30 | 17.21% | ๐จ๐ญ Switzerland |
Pfizer PFE | 1.67 | -54.61% | ๐บ๐ธ USA |
Sanofi SNY | 1.42 | -61.44% | ๐ซ๐ท France |
GlaxoSmithKline GSK | 5.13 | 39.63% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | 1.81 | -50.60% | ๐ฎ๐ฑ Israel |